{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:26:43Z","timestamp":1787329603114,"version":"build-2736575974"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730008"],"award-info":[{"award-number":["81730008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800139"],"award-info":[{"award-number":["81800139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870080"],"award-info":[{"award-number":["81870080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.canlet.2022.215920","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T08:59:07Z","timestamp":1663405147000},"page":"215920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective"],"prefix":"10.1016","volume":"550","author":[{"given":"Xiaohui","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215920_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1\u20132 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2022.215920_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215920_bib3","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/s41409-019-0487-3","article-title":"Early and late hematologic toxicity following CD19 CAR-T cells","volume":"54","author":"Fried","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2022.215920_bib5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1080\/10428194.2019.1697814","article-title":"Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT)","volume":"61","author":"Nahas","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2022.215920_bib6","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3324\/haematol.2020.254045","article-title":"Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma","volume":"106","author":"Strati","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2022.215920_bib7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood.2020010543","article-title":"CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed\/refractory large B-cell lymphoma","volume":"138","author":"Rejeski","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004475","article-title":"The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R\/R LBCL","volume":"10","author":"Rejeski","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2022.215920_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2015.64.5929","article-title":"Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease","volume":"34","author":"Brudno","year":"2016","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canlet.2022.215920_bib10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib11","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2013-08-519413","article-title":"Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation","volume":"122","author":"Kochenderfer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib12","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/bloodadvances.2020002509","article-title":"Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies","volume":"4","author":"Jain","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2022.215920_bib13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3324\/haematol.2019.238634","article-title":"Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma","volume":"106","author":"Logue","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2022.215920_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.26113","article-title":"Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies","volume":"96","author":"Nagle","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2022.215920_bib15","article-title":"New-onset severe cytopenia after CAR-T cell therapy: analysis of 76 patients with relapsed or refractory acute lymphoblastic leukemia","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2022.215920_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"Cancer J."},{"key":"10.1016\/j.canlet.2022.215920_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.omto.2019.08.002","article-title":"Parallel comparison of 4-1BB or CD28 Co-stimulated CD19-targeted CAR-T cells for B cell non-hodgkin's lymphoma","volume":"15","author":"Ying","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.canlet.2022.215920_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061501","article-title":"Cytopenia after CAR-T cell therapy-A brief review of a complex problem","volume":"14","author":"Sharma","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215920_bib19","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ajh.25951","article-title":"Commercial anti-CD19 CAR T cell therapy for patients with relapsed\/refractory aggressive B cell lymphoma in a European center","volume":"95","author":"Sesques","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2022.215920_bib20","volume":"138","author":"John","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib22","series-title":"Acute and Delayed Cytopenias Following CAR T-Cell Therapy: an Investigation of Risk Factors and Mechanisms","first-page":"1","author":"Brudno","year":"2022"},{"key":"10.1016\/j.canlet.2022.215920_bib23","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020705","article-title":"Bone marrow failure syndromes, overlapping diseases with a common cytokine signature","volume":"22","author":"Giudice","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2022.215920_bib25","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41409-021-01403-w","article-title":"Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis","volume":"56","author":"Abboud","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2022.215920_bib26","first-page":"277","article-title":"Macrophage activation syndrome and cytokine-directed therapies, Best practice & research","volume":"28","author":"Schulert","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.canlet.2022.215920_bib27","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/sj.leu.2402684","article-title":"The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD\/SCID and NOD\/SCID\/B2m(null) mice","volume":"16","author":"Lapidot","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2022.215920_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2004-08-3198","article-title":"B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis","volume":"106","author":"Dunleavy","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib30","article-title":"Unity brings strength: combination of CAR-T cell therapy and HSCT","author":"Huang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215920_bib31","article-title":"CAR-T cell therapy in hematological malignancies: current opportunities and challenges","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib32","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41409-020-01006-x","article-title":"G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory\/relapsed B-cell lymphoma","volume":"55","author":"Galli","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2022.215920_bib33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1681\/ASN.2019030266","article-title":"Erythropoiesis-stimulating agents and mortality","volume":"30","author":"Drueke","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.canlet.2022.215920_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12703\/P6-45","article-title":"Management of thrombocytopenia","volume":"6","author":"Izak","year":"2014","journal-title":"F1000prime Rep."},{"key":"10.1016\/j.canlet.2022.215920_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"in, Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2022.215920_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2386187","article-title":"Immunotherapy with CAR-modified T cells: toxicities and overcoming strategies","volume":"2018","author":"Sun","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.canlet.2022.215920_bib37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2018.03.024","article-title":"Niches for hematopoietic stem cells and their progeny","volume":"48","author":"Wei","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2022.215920_bib38","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2018-03-791517","article-title":"Differentiation-based model of hematopoietic stem cell functions and lineage pathways","volume":"132","author":"Hofer","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.stem.2014.07.005","article-title":"Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis","volume":"15","author":"Cabezas-Wallscheid","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251033","article-title":"Transcriptional diversity during lineage commitment of human blood progenitors","volume":"345","author":"Chen","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2022.215920_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib42","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20130751","article-title":"Gata2 is required for HSC generation and survival","volume":"210","author":"de Pater","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib43","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/bloodadvances.2021004726","article-title":"Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging","volume":"5","author":"Abdelfattah","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2022.215920_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood-2009-01-201384","article-title":"Scl regulates the quiescence and the long-term competence of hematopoietic stem cells","volume":"115","author":"Lacombe","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib45","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nature02994","article-title":"Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells","volume":"431","author":"Hock","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215920_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib47","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/leu.2011.127","article-title":"Notch signaling in mammalian hematopoietic stem cells","volume":"25","author":"Pajcini","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2022.215920_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1172\/JCI43868","article-title":"Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells","volume":"121","author":"Varnum-Finney","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2022.215920_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.stem.2013.05.015","article-title":"In vivo mapping of notch pathway activity in normal and stress hematopoiesis","volume":"13","author":"Oh","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-Catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215920_bib52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cell.2012.05.041","article-title":"Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche","volume":"150","author":"Sugimura","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.stemcr.2018.05.017","article-title":"TGF-beta1 negatively regulates the number and function of hematopoietic stem cells","volume":"11","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.canlet.2022.215920_bib55","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2008-04-146480","article-title":"TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation","volume":"113","author":"Yamazaki","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215920_bib57","first-page":"8","article-title":"Mesenchymal stem cell migration and tissue repair","author":"Fu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2022.215920_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215920_bib59","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2022.215920_bib60","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Mendez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215920_bib61","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215920_bib62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI82585","article-title":"Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair","volume":"126","author":"Hu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2022.215920_bib63","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1182\/blood.V98.13.3643","article-title":"Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1\/Waf1) or p27(Kip1)","volume":"98","author":"Cheng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib64","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ncb2108","article-title":"Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells","volume":"12","author":"Kobayashi","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215920_bib65","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.stem.2019.10.006","article-title":"Apelin(+) endothelial niche cells control hematopoiesis and mediate vascular regeneration after myeloablative injury","volume":"25","author":"Chen","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3324\/haematol.2018.211334","article-title":"Microenvironmental contributions to hematopoietic stem cell aging","volume":"105","author":"Ho","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2022.215920_bib67","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nri3660","article-title":"Emergency granulopoiesis","volume":"14","author":"Manz","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib71","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201169","article-title":"PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress","volume":"218","author":"Chavez","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib72","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0301-472X(99)00009-0","article-title":"Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity","volume":"27","author":"Yu","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2022.215920_bib73","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm.1973","article-title":"Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion","volume":"15","author":"Sato","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib74","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib75","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.4238\/2014.May.30.3","article-title":"Fas\/FasL in the immune pathogenesis of severe aplastic anemia","volume":"13","author":"Liu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.canlet.2022.215920_bib76","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2010-10-315218","article-title":"Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1\/PU.1 axis","volume":"118","author":"Libregts","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2022.215920_bib78","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2567.2010.03381.x","article-title":"Interplay of transcription factors in T-cell differentiation and function: the role of Runx","volume":"132","author":"Wong","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2022.215920_bib80","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood-2018-05-844928","article-title":"Macrophage TNF-alpha licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia","volume":"132","author":"Sun","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib81","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2011-11-390708","article-title":"Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.stem.2016.03.002","article-title":"TGF-Beta inhibition rescues hematopoietic stem cell defects and bone marrow failure in fanconi anemia","volume":"18","author":"Zhang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2022.215920_bib83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/ejh.12471","article-title":"Involvement of interleukin-21 in the pathophysiology of aplastic anemia","volume":"95","author":"Zhang","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.canlet.2022.215920_bib84","first-page":"285","article-title":"The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome","volume":"13","author":"Meliconi","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.canlet.2022.215920_bib85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V91.1.181","article-title":"Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases","volume":"91","author":"Bux","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib86","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2009.25.0274","article-title":"Immunoglobulin G Fc receptor FcgammaRIIIa 158 V\/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma","volume":"28","author":"Weng","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2022.215920_bib87","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3109\/10428194.2011.593276","article-title":"T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias","volume":"52","author":"Watters","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2022.215920_bib88","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1615\/CritRevImmunol.v26.i4.20","article-title":"Neutrophil infiltration and chemokines","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib89","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41422-020-00455-9","article-title":"Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages","volume":"31","author":"Wauters","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2022.215920_bib90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood-2007-07-099648","article-title":"The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation","volume":"111","author":"Wengner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib91","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(03)00263-2","article-title":"Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence","volume":"19","author":"Martin","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2022.215920_bib92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2567.2008.02950.x","article-title":"Neutrophil mobilization and clearance in the bone marrow","volume":"125","author":"Furze","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2022.215920_bib93","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib96","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-0609.2005.00622.x","article-title":"Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura","volume":"76","author":"Zhang","year":"2006","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.canlet.2022.215920_bib97","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","article-title":"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy","volume":"115","author":"Chow","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib98","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1182\/blood-2014-03-563445","article-title":"Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia","volume":"124","author":"Audia","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib99","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3324\/haematol.2018.214593","article-title":"Bone marrow endothelial cell-derived interleukin-4 contributes to thrombocytopenia in acute myeloid leukemia","volume":"104","author":"Gao","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2022.215920_bib100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib101","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.annonc.2020.10.478","article-title":"Side-effect management of chimeric antigen receptor (CAR) T-cell therapy","volume":"32","author":"Schubert","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2022.215920_bib102","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2022.215920_bib103","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.14194","article-title":"Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease","volume":"174","author":"Liang","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2022.215920_bib104","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1101\/gad.13.11.1398","article-title":"Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells","volume":"13","author":"Rekhtman","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2022.215920_bib105","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.89.14.6353","article-title":"Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors","volume":"89","author":"Sposi","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2022.215920_bib106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.ajkd.2017.09.026","article-title":"Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018","volume":"71","author":"Fishbane","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.canlet.2022.215920_bib107","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.canlet.2022.215920_bib108","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.0409808102","article-title":"Regulation of hepcidin transcription by interleukin-1 and interleukin-6","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2022.215920_bib109","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3041738","article-title":"Effect of interleukin and hepcidin in anemia of chronic diseases","volume":"2020","author":"Yacoub","year":"2020","journal-title":"Anemia"},{"key":"10.1016\/j.canlet.2022.215920_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3457347","article-title":"A comparative study of interleukin 6, inflammatory markers, ferritin, and hematological profile in rheumatoid arthritis patients with anemia of chronic disease and iron deficiency anemia","volume":"2019","author":"Ali","year":"2019","journal-title":"Anemia"},{"key":"10.1016\/j.canlet.2022.215920_bib111","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nm.3468","article-title":"An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia","volume":"20","author":"Dussiot","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib112","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajh.20644","article-title":"Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases","volume":"81","author":"Mitlyng","year":"2006","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2022.215920_bib113","series-title":"Autoimmune Hemolytic Anemia","first-page":"382","volume":"vol. 2018","author":"Hill","year":"2018"},{"key":"10.1016\/j.canlet.2022.215920_bib114","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.exphem.2012.08.008","article-title":"Critical role of Th17 cells in development of autoimmune hemolytic anemia","volume":"40","author":"Xu","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2022.215920_bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.imbio.2011.07.032","article-title":"IL-12 inhibits the TGF-beta-dependent T cell developmental programs and skews the TGF-beta-induced differentiation into a Th1-like direction","volume":"217","author":"Prochazkova","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.canlet.2022.215920_bib116","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ejh.13187","article-title":"Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review","volume":"102","author":"Tanios","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.canlet.2022.215920_bib117","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.4049\/jimmunol.1900382","article-title":"IFN-gamma-Dependent reduction of erythrocyte life span leads to anemia during mycobacterial infection","volume":"203","author":"Gomes","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib118","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1128\/IAI.01149-15","article-title":"Bacterial stimulation of toll-like receptor 4 drives macrophages to hemophagocytose","volume":"84","author":"McDonald","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.canlet.2022.215920_bib119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fimmu.2017.00073","article-title":"From the cradle to the grave: the role of macrophages in erythropoiesis and erythrophagocytosis","volume":"8","author":"Klei","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2022.215920_bib120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00277-017-2957-2","article-title":"Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia","volume":"96","author":"Puigvi","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canlet.2022.215920_bib121","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12288-019-01226-2","article-title":"Erythrophagocytosis by neutrophil and monocyte in autoimmune hemolytic anemia after infection","volume":"36","author":"Lian","year":"2020","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.canlet.2022.215920_bib122","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fphys.2014.00084","article-title":"Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging","volume":"5","author":"Mohanty","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.canlet.2022.215920_bib123","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.193.8.925","article-title":"Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant","volume":"193","author":"Friedman","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib124","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1038\/s41467-020-17175-8","article-title":"Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma","volume":"11","author":"Hegde","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2022.215920_bib125","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/bloodadvances.2020004142","article-title":"Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy","volume":"6","author":"Juluri","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2022.215920_bib126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymthe.2017.01.011","article-title":"Inducible caspase-9 selectively modulates the toxicities of CD19-specific chimeric antigen receptor-modified T cells","volume":"25","author":"Diaconu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2022.215920_bib127","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1182\/blood.2021010784","article-title":"Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicity","volume":"137","author":"Foster","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215920_bib129","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215920_bib130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(21)00591-X","article-title":"Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Jacobson","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2022.215920_bib131","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood.2021014497","article-title":"Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL","volume":"139","author":"Gauthier","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215920_bib132","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:06:21Z","timestamp":1759593981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522004074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":132,"alternative-id":["S0304383522004074"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215920","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"215920"}}